Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-11-6
|
pubmed:abstractText |
In oncochemotherapy with methotrexate (MTX) a peripheral concentration greater than 0.45 mg/l and a plasma concentration less than 45 mg/l must be maintained for 20 h. The time periods required to reach and maintain steady-state concentrations after tapered and linear intravenous infusion were compared. Pharmacokinetic analyses according to a two-compartment model were used to calculate dosage regimens and concentration profiles by means of the Bayesian General Modelling Program (BM) and NONLIN. When the dosage regimen is based on a steady-state concentration in the peripheral compartment (which is the target compartment for MTX) tapered infusion reaches this concentration 40% faster and maintains it 12.5% longer, but no difference is found if the dosage regimen is based on a steady-state concentration in the central compartment. In theory the two-step 24-hour tapered infusion can be replaced by a bolus injection plus linear infusion in the ratio 1:2 of the total dose. These dosage regimens are to be preferred over linear infusion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0167-6555
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
158-62
|
pubmed:dateRevised |
2008-2-25
|
pubmed:meshHeading |
pubmed-meshheading:4047914-Humans,
pubmed-meshheading:4047914-Infusions, Parenteral,
pubmed-meshheading:4047914-Kinetics,
pubmed-meshheading:4047914-Male,
pubmed-meshheading:4047914-Methotrexate,
pubmed-meshheading:4047914-Middle Aged,
pubmed-meshheading:4047914-Models, Biological,
pubmed-meshheading:4047914-Neoplasms,
pubmed-meshheading:4047914-Statistics as Topic
|
pubmed:year |
1985
|
pubmed:articleTitle |
Comparison of linear and tapered intravenous infusion of methotrexate in oncochemotherapy. A theoretical approach.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|